165 related articles for article (PubMed ID: 32418797)
1. WHO working group meeting to develop WHO Recommendations to assure the quality, safety and efficacy of enterovirus 71 vaccines.
Lei D; Griffiths E; Martin J
Vaccine; 2020 Jul; 38(32):4917-4923. PubMed ID: 32418797
[TBL] [Abstract][Full Text] [Related]
2. Recent progress and advances towards developing enterovirus 71 vaccines for effective protection against human hand, foot and mouth disease (HFMD).
Bello AM; Roshorm YM
Biologicals; 2022 Sep; 79():1-9. PubMed ID: 36089444
[TBL] [Abstract][Full Text] [Related]
3. Enterovirus 71: a whole virion inactivated enterovirus 71 vaccine.
Zhou Y; Li JX; Jin PF; Wang YX; Zhu FC
Expert Rev Vaccines; 2016 Jul; 15(7):803-13. PubMed ID: 27206811
[TBL] [Abstract][Full Text] [Related]
4. Enterovirus 71 vaccine: close but still far.
Zhang D; Lu J; Lu J
Int J Infect Dis; 2010 Sep; 14(9):e739-43. PubMed ID: 20400350
[TBL] [Abstract][Full Text] [Related]
5. Development and characterization of an enterovirus 71 (EV71) virus-like particles (VLPs) vaccine produced in
Yang Z; Gao F; Wang X; Shi L; Zhou Z; Jiang Y; Ma X; Zhang C; Zhou C; Zeng X; Liu G; Fan J; Mao Q; Shi L
Hum Vaccin Immunother; 2020 Jul; 16(7):1602-1610. PubMed ID: 31403352
[TBL] [Abstract][Full Text] [Related]
6. Preclinical evaluation of recombinant HFMD vaccine based on enterovirus 71 (EV71) virus-like particles (VLP): Immunogenicity, efficacy and toxicology.
Wang Z; Zhou C; Gao F; Zhu Q; Jiang Y; Ma X; Hu Y; Shi L; Wang X; Zhang C; Liu B; Shen L; Mao Q; Liu G
Vaccine; 2021 Jul; 39(31):4296-4305. PubMed ID: 34167837
[TBL] [Abstract][Full Text] [Related]
7. Prospect and challenges for the development of multivalent vaccines against hand, foot and mouth diseases.
Liu CC; Chow YH; Chong P; Klein M
Vaccine; 2014 Oct; 32(47):6177-82. PubMed ID: 25218294
[TBL] [Abstract][Full Text] [Related]
8. A novel inactivated enterovirus 71 vaccine can elicit cross-protective immunity against coxsackievirus A16 in mice.
Yang L; Liu Y; Li S; Zhao H; Lin Q; Yu H; Huang X; Zheng Q; Cheng T; Xia N
Vaccine; 2016 Nov; 34(48):5938-5945. PubMed ID: 27771182
[TBL] [Abstract][Full Text] [Related]
9. [Research progress on immune efficacy, safety, vaccination intention and immunization strategy of domestic enterovirus 71 vaccine after its marketing].
Xu WJ; Chen EF
Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Sep; 54(9):1010-1016. PubMed ID: 32907294
[TBL] [Abstract][Full Text] [Related]
10. EV71 vaccine, a new tool to control outbreaks of hand, foot and mouth disease (HFMD).
Mao QY; Wang Y; Bian L; Xu M; Liang Z
Expert Rev Vaccines; 2016 May; 15(5):599-606. PubMed ID: 26732723
[TBL] [Abstract][Full Text] [Related]
11. Crystal Structures of Yeast-Produced Enterovirus 71 and Enterovirus 71/Coxsackievirus A16 Chimeric Virus-Like Particles Provide the Structural Basis for Novel Vaccine Design against Hand-Foot-and-Mouth Disease.
Lyu K; He YL; Li HY; Chen R
J Virol; 2015 Jun; 89(12):6196-208. PubMed ID: 25833050
[TBL] [Abstract][Full Text] [Related]
12. EV71: an emerging infectious disease vaccine target in the Far East?
Xu J; Qian Y; Wang S; Serrano JM; Li W; Huang Z; Lu S
Vaccine; 2010 Apr; 28(20):3516-21. PubMed ID: 20304038
[TBL] [Abstract][Full Text] [Related]
13. Trend of hand, foot, and mouth disease from 2010 to 2021 and estimation of the reduction in enterovirus 71 infection after vaccine use in Zhejiang Province, China.
Wu H; Xue M; Wu C; Lu Q; Ding Z; Wang X; Fu T; Yang K; Lin J
PLoS One; 2022; 17(9):e0274421. PubMed ID: 36126038
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of monovalent and bivalent vaccines against lethal Enterovirus 71 and Coxsackievirus A16 infection in newborn mice.
Sun S; Jiang L; Liang Z; Mao Q; Su W; Zhang H; Li X; Jin J; Xu L; Zhao D; Fan P; An D; Yang P; Lu J; Lv X; Sun B; Xu F; Kong W; Jiang C
Hum Vaccin Immunother; 2014; 10(10):2885-95. PubMed ID: 25483672
[TBL] [Abstract][Full Text] [Related]
15. Preclinical safety assessment of a combined vaccine against Hepatitis a virus and enterovirus 71.
Yang T; Liu B; Yue L; Xie T; Li H; Shao M; Yang R; Luo F; Long R; Xie Z
Vaccine; 2021 Jun; 39(29):3952-3963. PubMed ID: 34088510
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of Hand, Foot, and Mouth Disease Before and After the Introduction of Enterovirus 71 Vaccines in Chengdu, China, 2009-2018.
Han Y; Chen Z; Zheng K; Li X; Kong J; Duan X; Xiao X; Guo B; Luan R; Long L
Pediatr Infect Dis J; 2020 Oct; 39(10):969-978. PubMed ID: 32433221
[TBL] [Abstract][Full Text] [Related]
17. Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Zhu FC; Meng FY; Li JX; Li XL; Mao QY; Tao H; Zhang YT; Yao X; Chu K; Chen QH; Hu YM; Wu X; Liu P; Zhu LY; Gao F; Jin H; Chen YJ; Dong YY; Liang YC; Shi NM; Ge HM; Liu L; Chen SG; Ai X; Zhang ZY; Ji YG; Luo FJ; Chen XQ; Zhang Y; Zhu LW; Liang ZL; Shen XL
Lancet; 2013 Jun; 381(9882):2024-32. PubMed ID: 23726161
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive safety assessment of a human inactivated diploid enterovirus 71 vaccine based on a phase III clinical trial.
Zhang W; Kong Y; Jiang Z; Li C; Wang L; Xia J
Hum Vaccin Immunother; 2016 Apr; 12(4):922-30. PubMed ID: 26837471
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus core particles containing multiple epitopes confer protection against enterovirus 71 and coxsackievirus A16 infection in mice.
Huo C; Yang J; Lei L; Qiao L; Xin J; Pan Z
Vaccine; 2017 Dec; 35(52):7322-7330. PubMed ID: 29129453
[TBL] [Abstract][Full Text] [Related]
20. A safety study of inactivated Enterovirus 71 vaccine.
Zhou XB; Lu JJ; Jiang YS; Huo Y; Wang JF; Zhou KF; Li B
Hum Vaccin Immunother; 2013 Jul; 9(7):1430-7. PubMed ID: 23571172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
